Abstract
In this report, two patients with essential thrombocythemia and somatic mutations in the gene encoding calreticulin but no mutations in the Janus kinase 2 gene had a response to interferon alfa therapy.
Cite
CITATION STYLE
APA
Cassinat, B., Verger, E., & Kiladjian, J.-J. (2014). Interferon Alfa Therapy in CALR -Mutated Essential Thrombocythemia. New England Journal of Medicine, 371(2), 188–189. https://doi.org/10.1056/nejmc1401255
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free